首页|血清微小RNA-184、微小RNA-451a表达对Ⅰ~ⅡA期非小细胞肺癌根治术后复发转移的预测价值

血清微小RNA-184、微小RNA-451a表达对Ⅰ~ⅡA期非小细胞肺癌根治术后复发转移的预测价值

扫码查看
目的 探讨血清微小核糖核酸(miRNA)-184、miR-451a表达对Ⅰ~ⅡA期非小细胞肺癌(NSCLC)根治术后复发转移的预测价值。方法 选取2020年1月-2021年10月在本院行根治性切除术的203例Ⅰ~ⅡA期NSCLC患者为NSCLC组,随访2年根据复发转移情况分为复发转移组30例和无复发转移组173例;另选取同期87名体检健康志愿者为对照组。采用实时荧光定量聚合酶链式反应检测血清miR-184、miR-451a表达。采用多因素Logistic回归模型分析影响Ⅰ~Ⅱ A期NSCLC根治术后复发转移的因素;采用受试者工作特征(ROC)曲线分析血清miR-184、miR-451a表达对复发转移的预测价值。结果 与对照组比较,NSCLC组血清miR-184、miR-451a表达降低,差异有统计学意义(P<0。05)。随访2年,203例Ⅰ~ⅡA期NSCLC患者术后复发转移率为14。78%(30/203)。与无复发转移组比较,复发转移组血清miR-184、miR-451a表达降低,差异有统计学意义(P<0。05)。Ⅰ~ⅡA期NSCLC根治术后复发转移的独立危险因素为ⅡA期、低分化、术后辅助化疗,独立保护因素为miR-184升高、miR-451a升高(P<0。05)。血清miR-184、miR-451a表达联合预测Ⅰ~ⅡA期NSCLC根治术后复发转移的曲线下面积为0。868,大于血清miR-184、miR-451a表达单独预测的0。784、0。781,差异有统计学意义(P<0。05)。结论 Ⅰ~ⅡA期NSCLC患者血清miR-184、miR-451a呈低表达,与根治术后复发转移密切相关,血清miR-184、miR-451a联合检测对Ⅰ~Ⅱ A期NSCLC根治术后复发转移有较高的预测价值。
Value of serum microRNA-184 and microRNA-451a expression in predicting recurrent metastasis after radical surgery of patients with non-small cell lung cancer in stage Ⅰ to Ⅱ A
Objective To investigate the value of serum microRNA(miRNA)-184 and miR-451a expression in predicting recurrent metastasis after radical resection of stage Ⅰ to Ⅱ A non-small cell lung cancer(NSCLC).Methods A total of 203 patients with radical resection of stage Ⅰ to Ⅱ A NSCLC in the hospital from January 2020 to October 2021 were selected as NSCLC group.According to the recurrence and metastasis status during the 2-year follow-up,they were divided into recurrence and metastasis group with 30 cases and non-recurrence and metastasis group with 173 cases.Addition-ally,87 healthy volunteers with physical examinations in the same period were selected as control group.Real-time quantitative polymerase chain reaction was used to detect serum expression of miR-184 and miR-451a.Multivariate Logistic regression model was used to analyze the factors affecting recurrence and metastasis after radical resection of stage Ⅰ to Ⅱ A NSCLC.Receiver operating characteristic(ROC)curve was used to analyze the value of serum miR-184 and miR-451 a expression in predicting recurrence and metastasis.Results Compared with the control group,the expression of serum miR-184 and miR-451a in the NSCLC group decreased significantly(P<0.05).After 2 years of follow-up,the recurrence and metastasis rate of 203 patients with stage Ⅰ to ⅡA NSCLC was 14.78%(30/203).Compared with the non-recurrence and metastasis group,the expression of serum miR-184 and miR-451a in the recurrence and metastasis group decreased significantly(P<0.05).The independent risk factors for recurrence and metastasis after radical resection of stage Ⅰ to Ⅱ A NSCLC were stage Ⅱ A,poor differentiation and postoperative adjuvant chemotherapy,while the independent protective factors were increased miR-184 and miR-451a expression(P<0.05).The area under the curve(AUC)of the combined prediction of serum miR-184 and miR-45 1 a expression for recurrence and metastasis after radical resection of stage Ⅰ to Ⅱ A NSCLC was 0.868,which was greater than 0.784 and 0.781 of serum miR-184 and miR-451 a expression alone(P<0.05).Conclusion The serum miR-184 and miR-451a expression in patients with stage Ⅰ to ⅡA NSCLC is low and closely re-lated to recurrence and metastasis after radical resection.The combined detection of serum miR-184 and miR-451a has a high predictive value for recurrence and metastasis after radical resection of stage Ⅰ to ⅡA NSCLC.

non-small cell lung cancerradical resectionmicroRNA-184microRNA-451arecurrence and metastasis

范骏、魏可、骆金华、薛磊

展开 >

南京医科大学第一附属医院胸外科,江苏南京,210000

非小细胞肺癌 根治性切除术 微小核糖核酸-184 微小核糖核酸-451a 复发转移

国家自然青年科学基金项目

82203577

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(13)
  • 17